Worth reading
59In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Series 12 stock acquisition rights issued through a third-party allotment (with an exercise price adjustment clause)
発行・処分する株式数0Shares
Shares delivered during the month: 0 shares
Intended allottee
EVO FUND (the allottee of the previously issued Stock Acquisition Rights)
発行済株式総数
Exercise ratio during the month: 0.0%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥151; the minimum exercise price was ¥150 from 3 September to 30 September. The minimum exercise price is subject to an adjustment clause.
Number of Stock Acquisition Rights
Total issued: 60,000; unexercised balance at the end of the month preceding the reporting month: 34,840; unexercised balance at month-end: 34,840
Procedures under the Corporate Code of Conduct
The status of compliance with the exercise restrictions under Article 434 of the Listing Regulations is disclosed.
Most recent equity financing
Issued on 8 December 2025: Series 12 stock acquisition rights allocated to EVO FUND (with an exercise price adjustment clause)
| Item | Details |
|---|---|
| Type of issuance or disposal | Series 12 stock acquisition rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 0 shares |
| Intended allottee | EVO FUND (the allottee of the previously issued Stock Acquisition Rights) |
| Dilution Rate | Exercise ratio during the month: 0.0% |
| Total number of issued shares | As of the end of the month preceding the reporting month: 9,360,419 shares → Not disclosed |
| Exercise price | ¥151; the minimum exercise price was ¥150 from 3 September to 30 September. The minimum exercise price is subject to an adjustment clause. |
| Number of Stock Acquisition Rights | Total issued: 60,000; unexercised balance at the end of the month preceding the reporting month: 34,840; unexercised balance at month-end: 34,840 |
| Procedures under the Corporate Code of Conduct | The status of compliance with the exercise restrictions under Article 434 of the Listing Regulations is disclosed. |
| Most recent equity financing | Issued on 8 December 2025: Series 12 stock acquisition rights allocated to EVO FUND (with an exercise price adjustment clause) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of these stock acquisition rights for September 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.